Relationship between brain metastasis and thyroid transcription factor 1.

Area of Science:

• Oncology
• Neurology
• Molecular Biology

Background:

• Brain metastases (BMs) are a frequent complication of lung adenocarcinomas (ACs).
• Thyroid transcription factor 1 (TTF-1) is a crucial marker in AC diagnosis.
• The prognostic significance of TTF-1 in AC patients with BMs requires further investigation.

Purpose of the Study:

• To investigate the association between TTF-1 expression and the development of BMs in lung adenocarcinoma.
• To evaluate the impact of TTF-1 status on survival outcomes in AC patients with BMs.
• To determine the potential of TTF-1 as a prognostic biomarker in this patient population.

Main Methods:

• Retrospective analysis of 137 lung adenocarcinoma patients diagnosed with BMs between 2009 and 2020.
• Assessment of TTF-1 expression status (positive/negative) in tumor samples.
• Correlation analysis of TTF-1 status, ECOG performance score, age, and survival time using univariate and multivariance models.

Main Results:

• TTF-1 was positive in 73% of patients.
• Univariate and multivariance analyses revealed a significant correlation between survival time and TTF-1 status (p=0.024 and p=0.034, respectively).
• TTF-1 positive patients demonstrated a longer median survival (7 months) compared to TTF-1 negative patients (5.8 months).

Conclusions:

• TTF-1 status is significantly associated with survival outcomes in lung adenocarcinoma patients with brain metastases.
• TTF-1 can serve as a valuable biomarker for prognostic assessment and guiding treatment decisions.
• Further research is warranted to explore the underlying mechanisms and therapeutic implications of TTF-1 in AC with BMs.